Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
A Study of Daratumumab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Granix to Disrupt the Bone Marrow Microenvironment in Patients With Multiple Myeloma Undergoing Autologous Transplantation
- Status
- TERMINATED
- Phase
- PHASE2
Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Microdose Study of Melphalan, Bortezomib and Dexamethasone
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients
- Status
- COMPLETED
- Phase
- PHASE2
Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Plitidepsin (Aplidin®) in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Oligosecretary Myeloma: Prevalence and Its Clinical Significance
- Status
- COMPLETED
- Phase
- N/A
Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy
- Status
- UNKNOWN
- Phase
- PHASE2
Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- NA
Tolerability and Efficacy of Modified VCD Regimens in Previously Untreated Multiple Myeloma.
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Avastin (Bevacizumab) in Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Level of Physical Activity and Its Associations With Fatigue and Quality of Life in Multiple Myeloma Survivors
- Status
- UNKNOWN
- Phase
- N/A
A Phase II Trial Using Meloxicam Plus Filgrastim in Patients With Multiple Myeloma and Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Pidilizumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
A Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3